Search results - 16 results
Linkage of individual-patient data confirm protection of prophylactic human papillomavirus vaccination against invasive cervical cancer
HPV human papillomavirus patient data Vaccination Abstract: INTRODUCTION The Scottish study of Palmer et al., published in the current issue of this journal, linking vaccination files with cervical ...
Clinical performance of the novel full-genotyping OncoPredict HPV Quantitative Typing assay using the VALGENT framework.
Infections Reproducibility of Results Sensitivity and Specificity Uterine Cervical Dysplasia Uterine Cervical Neoplasms Young adult Abstract: Clinical validation of human papillomavirus (HPV) assays according ...
Human papillomavirus negative high grade cervical lesions and cancers: Suggested guidance for HPV testing quality assurance
Publication Type: Peer reviewed scientific article Authors: Prétet, Jean Luc; Arroyo Mühr, Laila Sara; Cuschieri, Kate; Fellner, María Dolores; Correa, Rita Mariel; Picconi, María Alejandra; Garland, Suzanne M.; Murray, Gerald L.; Molano, Monica; Michael ...
Can REALQUALITY RQ-HPV screen be considered as a clinically validated HPV test for use in cervical cancer screening?
Detection of Cancer Female Humans Mass Screening Papillomaviridae Papillomavirus Infections Uterine Cervical Dysplasia Uterine Cervical Neoplasms Vaginal Smears Abstract: “Can REALQUALITY RQ- HPV screen be ...
HPV-based Cervical Cancer Screening on Self-samples in the Netherlands: Challenges to Reach Women and Test Performance Questions.
Uterine Cervical Neoplasms Abstract: In 2017, cervical cancer screening in the Netherlands switched from cytology to human papillomavirus (HPV) testing using the validated PCR-based cobas 4800. Women could ...
Evaluation of the clinical performance of OncoPredict HPV® SCR assay within the VALGENT‐2 framework
Kate; M. Arbyn Source: Journal of Medical Virology, Volume 95, Issue 1 (2023) Keywords: cervical cancer HPV genotyping human papillomavirus OncoPredict HPV® test validation. VALGENT Abstract: Human ...
Accuracy of high-risk HPV DNA PCR, p16(INK4a) immunohistochemistry or the combination of both to diagnose HPV-driven oropharyngeal cancer
Madhavan Radhakrishna; Sankaranarayanan, Rengaswamy; Bogers, Johannes; Pawlita, Michael; Tommasino, Massimo; M. Arbyn Source: BMC Infectious Diseases, Volume 22 (2022) Keywords: HPV DNA PCR; p16(INK4a) IHC; ...
HPV DNA genotyping, HPV E6*I mRNA detection, and p16INK4a/Ki-67 staining in Belgian head and neck cancer patient specimens, collected within the HPV-AHEAD study
Madhavan Radhakrishna; Radhakrishna, Madhavan; Bogers, Johannes; Pawlita, Michael; Tommasino, Massimo; M. Arbyn; HPV-AHEAD study group Source: Cancer Epidemioly, Volume 72 (2021) Keywords: Adult Aged Aged, ...
Development and validation of a protocol for optimizing the use of paraffin blocks in molecular epidemiological studies: The example from the HPV-AHEAD study.
Lucas, Eric; Anantharaman, Devasena; Gheit, Tarik; Castellsagué, Xavier; Pawlita, Michael; de Sanjosé, Silvia; Alemany, Laia; Tommasino, Massimo; M. Arbyn; Cindy Simoens; HPV-AHEAD study group Source: PLoS ...
Presentation of the National Reference Centre for Human Papillomavirus in Belgium
Publication Type: Scientific poster, presentation or proceeding Authors: Steven Van Gucht Source: HPV Symposium and AML-Riatol chair inauguration, NA, Issue UA, NA (2016) Keywords: Belgium HPV Human ...